Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Time-dependent interaction between phenytoin and valproic acid.

R Riva, F Albani, M Contin

    Neurology
    |April 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Mutant FGFR3 associated with SADDAN disease causes cytoskeleton disorganization through PLCγ1/Src-mediated paxillin hyperphosphorylation.

    The international journal of biochemistry & cell biology·2017
    Same author

    Midazolam vs diazepam in prolonged seizures in children: A pharmacoeconomic approach.

    Acta neurologica Scandinavica·2017
    Same author

    Pattern of care and effectiveness of treatment for glioblastoma patients in the real world: Results from a prospective population-based registry. Could survival differ in a high-volume center?

    Neuro-oncology practice·2015
    Same author

    Protective activity of α-lactoalbumin (ALAC), a whey protein rich in tryptophan, in rodent models of epileptogenesis.

    Neuroscience·2012
    Same author

    Nifedipine versus fenoterol in the management of preterm labor: a randomized, multicenter clinical study.

    Gynecologic and obstetric investigation·2012
    Same author

    SPARTACUS: underdiagnosis of chronic daily headache in primary care.

    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2012
    Same journal

    Factors Associated With Disability Improvement and Worsening Independent of Attacks in Patients With AQP4-IgG+ NMOSD and MOGAD: A Multicenter Cohort Study.

    Neurology·2026
    Same journal

    Cost-Effectiveness of Intracranial Aneurysm Screening: A Systematic Review.

    Neurology·2026
    Same journal

    Rare Eating Epilepsy: Co-Occurrence of Focal Cortical Dysplasia and Gray Matter Heterotopia.

    Neurology·2026
    Same journal

    Spatiotemporal Associations Between Cortical Microinfarcts and Cortical Superficial Siderosis in Cerebral Amyloid Angiopathy.

    Neurology·2026
    Same journal

    Blood-Brain Barrier Disruption Before Interhospital Transfer for Thrombectomy and Clinical Outcome.

    Neurology·2026
    Same journal

    At Death's Door: Cytosolic Dopamine in Patients With Parkinson Disease.

    Neurology·2026
    See all related articles

    Valproic acid (VPA) significantly increases unbound phenytoin (PHT) levels throughout the day in epileptic patients. This drug interaction, affecting free PHT concentrations, shows diurnal variation linked to VPA plasma levels.

    Area of Science:

    • Pharmacology
    • Clinical Pharmacy
    • Neuroscience

    Background:

    • Phenytoin (PHT) is a widely used antiepileptic drug.
    • Valproic acid (VPA) is often used as combination therapy for epilepsy.
    • Drug interactions can significantly alter PHT pharmacokinetics.

    Purpose of the Study:

    • To investigate the diurnal variation of total and free plasma PHT concentrations.
    • To assess the impact of VPA coadministration on PHT diurnal variation.
    • To explore the relationship between VPA and PHT levels.

    Main Methods:

    • Studied eight epileptic patients on combination PHT and VPA therapy.
    • Included a control group of eight patients on PHT monotherapy.
    • Measured total and free PHT concentrations at steady state throughout the day.

    Related Experiment Videos

  • Correlated diurnal changes with plasma VPA concentrations.

    • Main Results:

    • In the absence of VPA, PHT concentrations showed minimal diurnal fluctuation.
    • With VPA, free PHT concentrations increased significantly during the day.
    • The free PHT fraction was higher and fluctuated more in patients receiving VPA.
    • Diurnal changes in free PHT correlated positively with plasma VPA levels.

    Conclusions:

    • The displacement interaction between PHT and VPA exhibits diurnal variation.
    • Fluctuations in plasma VPA likely drive the diurnal changes in free PHT.
    • These findings highlight the importance of monitoring free PHT in patients on combined therapy.